Randomized cross-sectional study to compare HIV-1 specific antibody and cytokine concentrations in female genital secretions obtained by menstrual cup and cervicovaginal lavage

PLoS ONE

Volumn 10, Issue 7, 2015, Pages

  Archary, Derseree ^a   Liebenberg, Lenine J ^a   Werner, Lise ^a   Tulsi, Sahil ^a   Majola, Nelisile ^a   Naicker, Nivashnee ^a   Dlamini, Sarah ^a   Hope, Thomas J ^b   Samsunder, Natasha ^a   Abdool Karim, Salim S ^a,c   Morris, Lynn ^a,d   Passmore, Jo Ann S ^a,e,f   Garrett, Nigel J ^a  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

^b NORTHWESTERN UNIVERSITY   (United States)

^c Department of Medicine   (United States)

^d NATIONAL INSTITUTE FOR COMMUNICABLE DISEASES   (South Africa)

^e UNIVERSITY OF CAPE TOWN   (South Africa)

^f NATIONAL HEALTH LABORATORY SERVICE   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

CUTANEOUS T CELL ATTRACTING CHEMOKINE; CYTOKINE; FIBROBLAST GROWTH FACTOR 2; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN G4; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 12P70; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 16; INTERLEUKIN 17; INTERLEUKIN 18; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; INTERLEUKIN 9; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ADULT; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; DEVICE REMOVAL; FEMALE; GENE PRODUCT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INTERMETHOD COMPARISON; LIKERT SCALE; LIMIT OF DETECTION; MENSTRUAL CUP; MUCOSAL IMMUNITY; PATIENT ATTITUDE; QUALITATIVE ANALYSIS; VAGINAL LAVAGE; VAGINAL SECRETION; BODY FLUID; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; MUCOSA; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; SPECIMEN HANDLING; UTERINE CERVIX; VAGINA;

HUMAN IMMUNODEFICIENCY VIRUS 1;

ADULT; BODY FLUIDS; CERVIX UTERI; COHORT STUDIES; CROSS-SECTIONAL STUDIES; CYTOKINES; FEMALE; HIV ANTIBODIES; HIV ANTIGENS; HIV INFECTIONS; HIV-1; HUMANS; IMMUNITY, MUCOSAL; IMMUNOGLOBULIN G; MUCOUS MEMBRANE; SPECIMEN HANDLING; VAGINA;

EID: 84940178934     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0131906     Document Type: Article

References (40)

1. Jespers V, Harandi AM, Hinkula J, Medaglini D, Le Grand R, Stahl-Hennig C, et al. Assessment of mucosal immunity to HIV-1. Expert Rev Vaccines. 2010 Apr; 9(4):381-94. doi: 10.1586/erv.10.21 PMID: 20370549
2. Quesnel A, Cu-Uvin S, Murphy D, Ashley RL, Flanigan T, Neutra MR. Comparative analysis of methods for collection and measurement of immunoglobulins in cervical and vaginal secretions of women. J Immunol Methods. 1997 Mar 28; 202(2):153-61. PMID: 9107304
3. Marks MA, Eby Y, Howard R, Gravitt PE. Comparison of normalization methods for measuring immune markers in cervical secretion specimens. J Immunol Methods. 2012 Aug 31; 382(1-2):211-5. doi: 10.1016/j.jim.2012.05.012 PMID: 22677266
4. Jespers V, Francis SC, van de Wijgert J, Crucitti T. Methodological issues in sampling the local immune system of the female genital tract in the context of HIV prevention trials. Am J Reprod Immunol. 2011 Mar; 65(3):368-76. doi: 10.1111/j.1600-0897.2010.00938.x PMID: 21199064
5. Dezzutti CS, Hendrix CW, Marrazzo JM, Pan Z, Wang L, Louissaint N, et al. Performance of swabs, lavage, and diluents to quantify biomarkers of female genital tract soluble mucosal mediators. PLoS One. 2011 Jan; 6(8):e23136. doi: 10.1371/journal.pone.0023136 PMID: 21858008
6. Omosa-Manyonyi G, Park H, Mutua G, Farah B, Bergin PJ, Laufer D, et al. Acceptability and feasibility of repeated mucosal specimen collection in clinical trial participants in Kenya. PLoS One. 2014 Jan; 9(10):e110228. doi: 10.1371/journal.pone.0110228 PMID: 25360819
7. Hordnes K, Trovik J, Tynning T, Haneberg B. Self-sampled and air-dried cervicovaginal secretions can be used for analyses of mucosal antibodies. J Immunol Methods. 1998 Nov; 220(1-2):151-9. PMID: 9839936
8. Snowhite I V, Jones WE, Dumestre J, Dunlap K, Braly PS, Hagensee ME. Comparative analysis of methods for collection and measurement of cytokines and immunoglobulins in cervical and vaginal secretions of HIV and HPV infected women. J Immunol Methods. 2002 May 1; 263(1-2):85-95. PMID: 12009206
9. Bélec L, Meillet D, Lévy M, Georges A, Tévi-Bénissan C, Pillot J. Dilution assessment of cervicovaginal secretions obtained by vaginal washing for immunological assays. Clin Diagn Lab Immunol. 1995 Jan; 2(1):57-61. PMID: 7719914
10. Castle PE, Rodriguez A-C, Bowman FP, Herrero R, Schiffman M, Bratti MC, et al. Comparison of ophthalmic sponges for measurements of immune markers from cervical secretions. Clin Diagn Lab Immunol. 2004 Mar; 11(2):399-405. PMID: 15013994
11. Seaton KE, Ballweber L, Lan A, Donathan M, Hughes S, Vojtech L, et al. HIV-1 Specific IgA Detected in Vaginal Secretions of HIV Uninfected Women Participating in a Microbicide Trial in Southern Africa Are Primarily Directed Toward gp120 and gp140 Specificities. PLoS One. 2014 Jan; 9(7):e101863. doi: 10.1371/journal.pone.0101863 PMID: 25054205
12. Price CF, Tyssen D, Sonza S, Davie A, Evans S, Lewis GR, et al. SPL7013 Gel (VivaGel®) retains potent HIV-1 and HSV-2 inhibitory activity following vaginal administration in humans. PLoS One. 2011 Jan; 6(9):e24095. doi: 10.1371/journal.pone.0024095 PMID: 21935377
13. Boskey ER, Moench TR, Hees PS, Cone RA. A self-sampling method to obtain large volumes of undiluted cervicovaginal secretions. Sex Transm Dis. 2003 Feb; 30(2):107-9. PMID: 12567165
14. Ndayisaba G, Verwijs MC, van Eeckhoudt S, Gasarabwe A, Hardy L, Borgdorff H, et al. Feasibility and acceptability of a novel cervicovaginal lavage self-sampling device among women in Kigali, Rwanda. Sex Transm Dis. 2013 Jul; 40(7):552-5. doi: 10.1097/OLQ.0b013e31828e5aa5 PMID: 23965769
15. Patel M V, Ghosh M, Fahey J V, Ochsenbauer C, Rossoll RM, Wira CR. Innate immunity in the vagina (Part II): Anti-HIV activity and antiviral content of human vaginal secretions. Am J Reprod Immunol. 2014 Jul; 72(1):22-33. doi: 10.1111/aji.12218 PMID: 24806967
16. Van Loggerenberg F, Mlisana K, Williamson C, Auld SC, Morris L, Gray CM, et al. Establishing a cohort at high risk of HIV infection in South Africa: challenges and experiences of the CAPRISA 002 acute infection study. PLoS One. 2008 Jan; 3(4):e1954. doi: 10.1371/journal.pone.0001954 PMID: 18414658
17. Shukair SA, Allen SA, Cianci GC, Stieh DJ, Anderson MR, Baig SM, et al. Human cervicovaginal mucus contains an activity that hinders HIV-1 movement. Mucosal Immunol. 2013 Mar; 6(2):427-34. doi: 10.1038/mi.2012.87 PMID: 22990624
18. Bebell LM, Passmore J-A, Williamson C, Mlisana K, Iriogbe I, van Loggerenberg F, et al. Relationship between levels of inflammatory cytokines in the genital tract and CD4+ cell counts in women with acute HIV-1 infection. J Infect Dis. 2008 Sep 1; 198(5):710-4. doi: 10.1086/590503 PMID: 18643751
19. Mlisana K, Naicker N, Werner L, Roberts L, van Loggerenberg F, Baxter C, et al. Symptomatic vaginal discharge is a poor predictor of sexually transmitted infections and genital tract inflammation in high-risk women in South Africa. J Infect Dis. 2012 Jul 1; 206(1):6-14. doi: 10.1093/infdis/jis298 PMID: 22517910
20. Tomaras GD, Yates NL, Liu P, Qin L, Fouda GG, Chavez LL, et al. Initial B-cell responses to transmitted human immunodeficiency virus type 1: virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremia. J Virol. 2008 Dec; 82 (24):12449-63. doi: 10.1128/JVI.01708-08 PMID: 18842730
21. Liu P, Overman RG, Yates NL, Alam SM, Vandergrift N, Chen Y, et al. Dynamic antibody specificities and virion concentrations in circulating immune complexes in acute to chronic HIV-1 infection. J Virol. 2011 Nov; 85(21):11196-207. doi: 10.1128/JVI.05601-11 PMID: 21865397
22. Zolla-Pazner S, deCamp A, Gilbert PB, Williams C, Yates NL, Williams WT, et al. Vaccine-induced IgG antibodies to V1V2 regions of multiple HIV-1 subtypes correlate with decreased risk of HIV-1 infection. Marques ETA, editor. PLoS One. Public Library of Science; 2014 Jan; 9(2):e87572. doi: 10.1371/journal.pone.0087572 PMID: 24504509
23. Yates NL, Lucas JT, Nolen TL, Vandergrift NA, Soderberg KA, Seaton KE, et al. Multiple HIV-1-specific IgG3 responses decline during acute HIV-1: implications for detection of incident HIV infection. AIDS. 2011 Nov 13; 25(17):2089-97. doi: 10.1097/QAD.0b013e32834b348e PMID: 21832938
24. Cummins JE, Doncel GF. Biomarkers of cervicovaginal inflammation for the assessment of microbicide safety. Sex Transm Dis. 2009 Mar; 36(3 Suppl):S84-91. doi: 10.1097/OLQ.0b013e3181994191 PMID: 19218890
25. Keller MJ, Herold BC. Understanding basic mechanisms and optimizing assays to evaluate the efficacy of vaginal microbicides. Sex Transm Dis. 2009 Mar; 36(3 Suppl):S92-5. doi: 10.1097/OLQ.0b013e318199417d PMID: 19218889
26. Chernesky M, Castriciano S, Jang D, Smieja M. Use of flocked swabs and a universal transport medium to enhance molecular detection of Chlamydia trachomatis and Neisseria gonorrhoeae. J Clin Microbiol. 2006 Mar; 44(3):1084-6. PMID: 16517899
27. Krech T, Castriciano S, Jang D, Smieja M, Enders G, Chernesky M. Detection of high risk HPV and Chlamydia trachomatis in vaginal and cervical samples collected with flocked nylon and wrapped rayon dual swabs transported in dry tubes. J Virol Methods. 2009 Dec; 162(1-2):291-3. doi: 10.1016/j.jviromet.2009.08.011 PMID: 19703493
28. Birse KM, Burgener A, Westmacott GR, McCorrister S, Novak RM, Ball TB. Unbiased proteomics analysis demonstrates significant variability in mucosal immune factor expression depending on the site and method of collection. PLoS One. 2013 Jan; 8(11):e79505. doi: 10.1371/journal.pone.0079505 PMID: 24244515
29. Bélec L, Ghys PD, Hocini H, Nkengasong JN, Tranchot-Diallo J, Diallo MO, et al. Cervicovaginal secretory antibodies to human immunodeficiency virus type 1 (HIV-1) that block viral transcytosis through tight epithelial barriers in highly exposed HIV-1-seronegative African women. J Infect Dis. 2001 Dec 1; 184(11):1412-22. PMID: 11709783
30. Chappell CA, Rohan LC, Moncla BJ, Wang L, Meyn LA, Bunge K, et al. The effects of reproductive hormones on the physical properties of cervicovaginal fluid. Am J Obstet Gynecol. 2014 Sep; 211(3):226. e1-7.
31. Devito C, Hinkula J, Kaul R, Lopalco L, Bwayo JJ, Plummer F, et al. Mucosal and plasma IgA from HIV-exposed seronegative individuals neutralize a primary HIV-1 isolate. AIDS. 2000 Sep 8; 14(13):1917-20. PMID: 10997395
32. Kaul R, Plummer F, Clerici M, Bomsel M, Lopalco L, Broliden K. Mucosal IgA in exposed, uninfected subjects: evidence for a role in protection against HIV infection. AIDS. 2001 Feb 16; 15(3):431-2. PMID: 11273233
33. Clerici M, Barassi C, Devito C, Pastori C, Piconi S, Trabattoni D, et al. Serum IgA of HIV-exposed uninfected individuals inhibit HIV through recognition of a region within the alpha-helix of gp41. AIDS. 2002 Sep 6; 16(13):1731-41. PMID: 12218383
34. Rowland-Jones S, Sutton J, Ariyoshi K, Dong T, Gotch F, McAdam S, et al. HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women. Nat Med. 1995 Jan; 1(1):59-64. PMID: 7584954
35. Rowland-Jones SL, Dong T, Fowke KR, Kimani J, Krausa P, Newell H, et al. Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi. J Clin Invest. 1998 Nov 1; 102(9):1758-65. PMID: 9802890
36. Erickson AL, Willberg CB, McMahan V, Liu A, Buchbinder SP, Grohskopf LA, et al. Potentially exposed but uninfected individuals produce cytotoxic and polyfunctional human immunodeficiency virus type 1-specific CD8(+) T-cell responses which can be defined to the epitope level. Clin Vaccine Immunol. 2008 Nov; 15(11):1745-8. doi: 10.1128/CVI.00247-08 PMID: 18815234
37. Choi RY, Levinson P, Guthrie BL, Lohman-Payne B, Bosire R, Liu AY, et al. Cervicovaginal HIV-1-neutralizing immunoglobulin A detected among HIV-1-exposed seronegative female partners in HIV-1-discordant couples. AIDS. 2012 Nov 13; 26(17):2155-63. doi: 10.1097/QAD.0b013e328359b99b PMID: 22948273
38. Mazzoli S, Trabattoni D, Lo Caputo S, Piconi S, Blé C, Meacci F, et al. HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals. Nat Med. 1997 Nov; 3(11):1250-7. PMID: 9359700
39. Alimonti JB, Kimani J, Matu L, Wachihi C, Kaul R, Plummer FA, et al. Characterization of CD8 T-cell responses in HIV-1-exposed seronegative commercial sex workers from Nairobi, Kenya. Immunol Cell Biol. 2006 Oct; 84(5):482-5. PMID: 16942489
40. Mitchell C, Paul K, Agnew K, Gaussman R, Coombs RW, Hitti J. Estimating volume of cervicovaginal secretions in cervicovaginal lavage fluid collected for measurement of genital HIV-1 RNA levels in women. J Clin Microbiol. 2011 Feb; 49(2):735-6. doi: 10.1128/JCM.00991-10 PMID: 21106793